Compared with the control group and before treatment , the frequency of respiratory tract infection was reduced in the treatment group 6 months and 12 months after treatment ( P < 0.05 ) , and serum levels of hBD-1 , IgA and IgG in the treatment group increased significantly ( P < 0.05 ) .